Surgical Aspects of Renal Transplantation

  • John D. Whelchel
Part of the Developments in Critical Care Medicine and Anesthesiology book series (DCCA, volume 14)

Abstract

Over eight million Americans have renal disease [1]. Each year thousands of these individuals develop renal failure and must consider either dialysis or transplantation to preserve their lives. Dialysis has dramatically improved and prolonged the lives of tens of thousands of patients suffering from renal failure. However, both patients and physicians agree that a successful transplant offers a superior quality of life over that of dialysis. In selected groups of patients, children, young adults [2], and diabetics [2, 3] transplantation is the preferred method of treatment. Due to the critical shortage of donor kidneys, the majority of patients choosing transplantation initially receive either hemodialysis or peritoneal dialysis treatments until a kidney becomes available.

Keywords

Catheter Creatinine Heparin Morphine Norepinephrine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    National Kidney Foundation, Inc. New York. Personal communication, June 1986.Google Scholar
  2. 2.
    Friedman EA: Kidney transplantation is the preferred therapy for uremia. Transplant Proc 17:1500, 1985.Google Scholar
  3. 3.
    Najarian JS, Sutherland ER: Biological basis for organ transplantation in diabetics. Transplant Proc 16:573, 1984.PubMedGoogle Scholar
  4. 4.
    Sutherland DER: Living related donors should be used whenever possible. Transplant Proc 17:1503, 1985.Google Scholar
  5. 5.
    Levey AS, Hou S, Bush HL: Kidney transplantation from unrelated living donors. N Engl J Med 314:914, 1986.PubMedCrossRefGoogle Scholar
  6. 6.
    Kreis H: Why living related donors should not be used whenever possible. Transplant Proc 17:1510, 1985.Google Scholar
  7. 7.
    Velosa JA, Anderson CF, Torres VE, et al.: Long-term renal status of kidney donors: calculated small risk of kidney donation. Transplant Proc 17:100, 1985.Google Scholar
  8. 8.
    Penn I, Halgrimson CG, Ogden D, et al.: Use of living donors in kidney transplantation in man. Arch Surg 101:226, 1970.PubMedGoogle Scholar
  9. 9.
    Anderson B, Hanson JB, Jorgenson SJ: Survival after nephrectomy. Scand J Urol Nephrol 2:91, 1968.CrossRefGoogle Scholar
  10. 10.
    Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Vincent F, Amend WJ, Kaysen G, et al.: Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects. Transplantation 36:626, 1983.CrossRefGoogle Scholar
  12. 12.
    End-Stage Renal Disease Program: Medical Information System Facility Survey Tables for 1982. Bethesda, MD: Department of Health and Human Services, Health Care Financing Administration, Bureau of Support Services, 1982, p. 1.Google Scholar
  13. 13.
    Bart KG, Macon EJ, Whittier FC, et al.: Cadaveric kidneys for transplantation. A paradox of shortage in the face of plenty. Transplantation 31:379, 1984.CrossRefGoogle Scholar
  14. 14.
    Phillips MG: Cadaver-donor nephrectomy. In: Urological Surgery, edited by Glenn JF. Philadelphia: JB Lippincott, 1983, p. 329.Google Scholar
  15. 15.
    Belzer FO: Perfusion preservation versus cold storage. Transplant Proc 17:1515, 1985.Google Scholar
  16. 16.
    Collins GM: The best method for renal preservation: cold storage. Transplant Proc 17:1518, 1986.Google Scholar
  17. 17.
    Salvatierra O, Olcott C, Amend WJ, et al.: Urological complications of renal transplantation can be prevented or controlled. J Urol 117:421, 1977.PubMedGoogle Scholar
  18. 18.
    McDonald JC, Rohr MS, Frentz GD: External ureteroneocystomstomy and ureterouretostomy in renal transplantation. Ann Surg 190:663, 1979.PubMedCrossRefGoogle Scholar
  19. 19.
    Whelchel JD, Cosimi AB, Young HH, et al.: Pyeloureterostomy reconstruction in human renal transplantation. Ann Surg 181:61, 1975.PubMedCrossRefGoogle Scholar
  20. 20.
    Opelz G, Terasaki PI: Studies on the strength of HLA antigens in related donor kidney transplants. Transplantation 24:106, 1977.PubMedCrossRefGoogle Scholar
  21. 21.
    Opelz G: Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation 40:240, 1985.PubMedCrossRefGoogle Scholar
  22. 22.
    Kahan BD, Kerman RH, Wideman CA, et al.: Impact of cyclosporine on renal transplant practice at the University of Texas Medical School at Houston. Am J Kidney Dis 5:288, 1985.PubMedGoogle Scholar
  23. 23.
    Ferguson RM, Sommer BG: Cyclosporine in renal transplantation: a single institutional experience. Am J Kidney Dis 5:296, 1985.PubMedGoogle Scholar
  24. 24.
    Kahan BD: Cyclosporine III. In: Diagnosis and Management of Associated Renal Injury, edited by Kahan BD. Orlando, FL: Grune and Stratton, 1985.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • John D. Whelchel

There are no affiliations available

Personalised recommendations